Treffer 1 - 4 von 4 für Suche 'Chaudhuri, Mitashri', Suchdauer: 0,28s Treffer weiter einschränken
  1. 1
    Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1

    Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1 von Huang, Min, O'Shaughnessy, Joyce, Haiderali, Amin, Pan, Wilbur, Hu, Peter, Chaudhuri, Mitashri, Le Bailly De Tilleghem, Celine, Cappoen, Nicolas, Fasching, Peter A.


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States

    Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the Uni... von Huang, Min, A. Fasching, Peter, Haiderali, Amin, Xue, Weiguang, Yang, Chelsey, Pan, Wilbur, Zhou, Zheng-Yi, Hu, Peter, Chaudhuri, Mitashri, Le Bailly De Tilleghem, Celine, Cappoen, Nicolas, O’Shaughnessy, Joyce

    Veröffentlicht in Advances in therapy

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Cost–effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancer

    Cost–effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancer von Huang, Min, Fasching, Peter, Haiderali, Amin, Pan, Wilbur, Gray, Emma, Zhou, Zheng-Yi, Hu, Peter, Chaudhuri, Mitashri, Bailly De Tilleghem, Celine Le, Cappoen, Nicolas, O’Shaughnessy, Joyce

    Veröffentlicht in Immunotherapy

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Cost-effectiveness of pembrolizumab plus chemotherapy as first line treatment in PD-L1-positive metastatic TNBC. Supplementary Tables

    Cost-effectiveness of pembrolizumab plus chemotherapy as first line treatment in PD-L1-positive metastatic TNBC. Supplementary Tables von O'Shaughnessy, Joyce, Cappoen, Nicolas, Tilleghem, Celine Le Bailly De, Zhou, Zheng-Yi, Gray, Emma, Pan, Wilbur James, Haiderali, Amin, Fasching, Peter, Huang, Min, Chaudhuri, Mitashri

    Volltext bestellen
    Dataset

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: